Finance

Lists
31R:FRA
Revive Therapeutics Ltd
0,010 €
0,00%
(0,00) 1D
9 қаз., 20:15:12 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 31R...
Mkt. cap
10,49 млн
Avg. vol.
2,94 мың
Volume
0,00
52-wk high
0,06 €
52-wk low
0,00 €
Mkt. cap
10,49 млн
Avg. vol.
2,94 мың
Volume
0,00
52-wk high
0,06 €
52-wk low
0,00 €
News stories
From web sources and news partners
About Revive Therapeutics Ltd
CEO-
Employees-
Founded2012
HeadquartersТоронто, Онтарио, Канада
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 ж. мау.
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
336,32 м.
200,14 м.
283,25 м.
242,05 м.
Operating expense
336,39 м.
220,13 м.
283,30 м.
463,87 м.
Total operating expenses
336,39 м.
220,13 м.
283,30 м.
463,87 м.
Operating income
-336,39 м.
-220,13 м.
-283,30 м.
-463,87 м.
Other non operating income
73,85 мың
-
-
-
EBT including unusual items
-9,60 млн
-281,75 м.
-238,72 м.
-506,50 м.
EBT excluding unusual items
-143,94 м.
-281,75 м.
-234,70 м.
-506,50 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9,60 млн
-281,75 м.
-238,72 м.
-506,50 м.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
277,00
-
-
Interest expense
-
-
-
-
Net interest expenses
-
277,00
-
-
Depreciation and amortization charges
62,00
46,00
48,00
47,00
EBITDA
-336,32 м.
-220,08 м.
-283,25 м.
-463,82 м.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары